Skip to content

Prieels Pharma

Active Risk: not assessed
Private limited companyfounded 2022active for 4 yearsBroekstraat 14, 3050 Oud-Heverlee, BelgiumKBO/BCE: BE 0787.996.326
Summary

Prieels Pharma has a registered holding activity and consists mainly of financial fixed assets. The bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €114,791 and a net result of €73,832. Equity has been growing by about 113% per year since 2022. Its solvency ranks better than 20% of 12,775 sector peers (NACE 47, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
Prieels PharmaActive
Risk analysis ReportCompare

Overview

Official details

Source: KBO
Status
Active since 04-07-2022 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730and 4 others
Establishment unit
2.334.913.427 3050 Oud-Heverlee, since 04-07-2022
Financial year end
31 December
Peppol
Reachable
Company details

Board and ownership

Board
Holdings
Shares in 1 company Apotheek Weert
Board & ownership

Financial position

Holding: outside the score modelBankruptcy probability: sector outside the model
Annual accounts 2025
Gross margin
€129,913
▲ 583%
Turnover
≈ €610,000
estimated
Profit
€73,832
▲ 433%
Equity
€114,791
▲ 180%
Total assets
€1.3m
▲ 367%
  • 2025 accounts filed 24 days after the deadline
Financials
Signalsraises risk2025 accounts filed 24 days lateShow the evidence

Checked score

Outside the general model
Holding: general score not applicable
The company has a registered holding activity. Financial fixed assets make up more than half of its assets. The general model for operating companies does not fit such a balance sheet, so there is no score and no financial strength.
Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

1 signal.
raises risk
raises risk · 2025 accounts filed 24 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 4 filings
Deviation from the deadline
2025
24 days late
2024
7 days late
2023
33 days early
2022
18 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 4 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 August (3 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2022.
KBO publications

Key points

  • Positive: Result rose in 2025from €13,861 to €73,832 ▲ 433% View
  • Caution: Lower solvency than 80% of companies in retail tradesector median 36.6% · 12,775 companies 8.9% View

Recent changes

  1. · Gazette deed IncorporationStarting capital €3,000 · Appointment: PRIEËLS Gijs Kristel Erik (director) · Permanent representative: PRIEËLS Gijs Kristel Erik
All 8 events

Comparable companies

These companies have the same main activity as Prieels Pharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.1m and €1.7m, founded between 2020 and 2023.

CompanyTotal assetsGross margin
Prieels Pharma Oud-Heverlee€1.3m€0.1m
PHARMA OZ Charleroi€1.2m€0.1m
PHARMA OGZ SRL Brussel€1.3m€0.2m
4Fonteinen Machelen (Brab.)€1.1m€0.2m
APKPHARMA Manage€1.1m€0.1m
CASSART PHARMA Silly€1.7m€0.1m
APOTHEEK THIELEMANS Beringen€1.4m€0.2m
Full comparison

Key facts about Prieels Pharma
What is the company number of Prieels Pharma?
The company number of Prieels Pharma is 0787.996.326. The VAT number is the same number with BE in front: BE 0787.996.326.
Where is Prieels Pharma based?
The registered office is at Broekstraat 14, 3050 Oud-Heverlee.Company details
What does Prieels Pharma do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Prieels Pharma?
The legal form of Prieels Pharma is Private limited company (BV).
When was Prieels Pharma founded?
Prieels Pharma was founded on 04-07-2022.
Is Prieels Pharma still active?
Yes, Prieels Pharma is an active enterprise in the KBO register.
What is the turnover of Prieels Pharma?
The turnover in financial year 2025 is ≈ €610,000. This figure is estimated from the gross margin of €129,913 and 51 comparable companies (NACE 477). It probably lies between €410,000 and €1.2m.Financials
Is Prieels Pharma profitable?
In financial year 2025, Prieels Pharma made a profit of €73,832.
Where can I find the annual accounts of Prieels Pharma?
Prieels Pharma filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Prieels Pharma due?
Prieels Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See what changed in the latest annual accounts.What changed See this company's board, registered office and name on a given date.Company as of a date

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure